In a model of early and aggressive vein graft stenosis in pigs, an intervention was performed with a single stent (n = 12 grafts), multiple stents (n = 6), or balloon angioplasty (n = 6), while grafts with mild stenoses were left untreated (n = 6). Four weeks after intervention, angiography showed that grafts with single stents, balloon angioplasty, or untreated grafts had patency rates of 92%, 83%, and 83%, respectively. Grafts receiving multiple stents, however, showed only a 17% patency rate (p < 0.05). Balloon dilatation or placement of a single stent improved the angiographic minimal diameter by 0.6 + 0.2 and 0.8 k 0.3 mm, respectively, over the short term, but this gain was lost during the follow-up period. Multiple stents showed a similar gain (0.5 + 0.2 mm) but more loss occurred during the follow-up period (2.4 t 0.2 mm). Histology revealed no significant differences between the treatment groups except for the prolonged presence of thrombus remnants in association with the stent wires. In conclusion, single stents and balloon angioplasty show good patency in early saphenous vein graft narrowing but multiple stents show a high occlusion rate. ( Coronary artery bypass graft (CABG) operations using autologous saphenous veins are a widely employed surgical therapy for obstructive atherosclerotic coronary artery disease. Up to 12% of grafts, however, occlude within 1 month after the operation, with an additional 10 % occlusion rate during the first year. A subsequent yearly occlusion rate of 2% has been reported, resulting in a 65% patency rate at 5 years. I, 2 Repeat byp ass surgery is feasible in most cases, but is associated with an increased morbidity and mortality, while long-term patency is inferior to that of the first procedure.3-5 Moreover, a significant number of patients for several reasons are poor candidates for repeat surgery.6 Percutaneous transluminal coronary angioplasty (PTCA) may be an alternative to surgery in these patients. The initial success rate of this procedure is high (90 % ), but the restenosis rate after PTCA in bypass graft is considerable, and only 41% of patients are alive and event-free af-
Coronary artery bypass graft (CABG) operations using autologous saphenous veins are a widely employed surgical therapy for obstructive atherosclerotic coronary artery disease. Up to 12% of grafts, however, occlude within 1 month after the operation, with an additional 10 % occlusion rate during the first year. A subsequent yearly occlusion rate of 2% has been reported, resulting in a 65% patency rate at 5 years. I, 2 Repeat byp ass surgery is feasible in most cases, but is associated with an increased morbidity and mortality, while long-term patency is inferior to that of the first procedure.3-5 Moreover, a significant number of patients for several reasons are poor candidates for repeat surgery.6 Percutaneous transluminal coronary angioplasty (PTCA) may be an alternative to surgery in these patients. The initial success rate of this procedure is high (90 % ), but the restenosis rate after PTCA in bypass graft is considerable, and only 41% of patients are alive and event-free af-ter 2 years7 Additionally, not all patients are candidates for balloon angioplasty. 6 The implantation of endovascular prostheses, also called stents, seems a promising new technique for treatment and prevention of restenosis in these patients.8p g The angiographic and histologic results after stent implantation in bypass grafts have only been reported to a limited extent.g-12 We therefore studied the placement of stents in an animal model for autologous saphenous vein graftingI and compared the results with those of balloon angioplasty alone, or with those following no intervention at all.
METHODS

Vein graft model. Experiments were performed in 31
Yorkshire pigs (17 to 30 kg; HVC, Hedel, The Netherlands). The protocol was approved by the Committee on Experimental Animals of Erasmus University. After an overnight fast the animals were sedated with 20 mg/kg ketamine hydrochloride (Ketalin; Apharmo BV, Arnhem, The Netherlands). Following endotracheal intubation, the pigs were connected to a ventilator that administered a mixture of oxygen and nitrous oxide (1:2, vol/vol). Anesthesia was maintained with 1 to 4 ~01% enflurane (Ethrane; Abbot BV, Maalderij, The Netherlands). Antibiotic prophylaxis was administered by an intramuscular injection of 1000 mg of a mixture of penicillin G procaine and penicillin G benzathine (Duplocillin; Gist-Brocades NV, Delft, The Netherlands).
The implantation of two venous grafts was performed 273 van Beusekom et al. Angelini, Bristol, England.) according to the methods described by Angelini et aLI3 (Fig. 1) . Briefly, skin incisions were made parallel to and approximately 3 cm lateral to the trachea on both sides. Both common carotid arteries were dissected free over a length of approximately 4 cm and were subsequently covered with gauze soaked in a 1% papaverine solution (Paparini sulfas; Centrafarm BV, Etten-leur, The Netherlands) to prevent vasospasm. The vena saphena minor of the left leg was prepared free over a distance of approximately 5 cm and the larger side branches were secured. After removal, the vein was overdistended using a syringe containing a solution of 1% papaverine and 10 U/ml of heparin (Thromboliquine;
Organon Teknika BV, Boxtel, The Netherlands).
Thereafter two pieces of vein, approximately 15 mm in length, were excised and stored in the same solution. After cross clamping of one carotid artery, a 15 mm piece of the vessel was removed and was replaced by a piece of saphenous vein by two end-to-end anastomoses using a 6.0 suture (Prolene; Ethicon, Norderstedt, Germany). After intravenous administration of 2500 U of heparin, the clamps were released. The contralateral carotid artery was grafted in an identical way. The anasto- February 1994 American Heart Journal motic sites were marked with stainless steel hemoclips. Neck and leg wounds were closed in layers using catgut (Chronic Gut; American Cyanamid Co., Wayne, N.J.) and the skin was covered with antiseptic spray (Nobecutane; Astra Pharmaceutics BV, Rijswijk, The Netherlands). Thereafter the animals were allowed to recover from anesthesia. Two animals died during the first days after surgery.
Follow-up angiography. Four weeks after surgery 29 animals were anesthetized as described above. Under sterile conditions an arteriotomy of a femoral artery was performed and a 9F introduction sheath was inserted. Then 5000 IU of heparin sodium was administered and an 8F guiding catheter was advanced to the aortic arch. After measurement of arterial blood pressure and heart rate and withdrawal of an arterial blood sample for the measurement of blood gases and acid-base balance (settings of the ventilator corrected, if necessary), angiography of the grafted carotid arteries was performed using iopamidol (Iopamiro 370; Dagra, Diemen, The Netherlands) as a contrast agent. Only animals with at least one patent graft were used for further study. One animal with two patent grafts was excluded from the study because of infection. In this animal the acute effect of 2 hours of stent placement was studied by scanning electron microscopy.
Balloon-expandable stent. The balloon-expandable stent used in this study (Wiktor, Medtronic Inc., Minneapolis, Minn.) is constructed of a single tantalum wire (0.127 mm in diameter) that is formed into a sinusoidal wave and wrapped into a helical coil structure. This prosthesis is crimped onto the deflated polyethylene balloon of a standard angioplasty catheter. The features of this prosthesis design are such that by inflating the balloon the diameter of the stent increases without alteration of its length.14 The maximal diameter of the balloon after inflation determines the ultimate size of the prosthesis after implantation.
One inflation at 8 atm is sufficient to open the stent and permit the safe withdrawal of the deflated balloon (Fig. 2) . The balloon diameters of the mounted angioplasty catheters used in this study were 4.0 mm, and the lengths of the prostheses were 14 to 16 mm.
Intervention. From the angiograms the patent grafts were divided into four groups by visual assessment (Table  I) . A first group of eight grafts (12 anastomotic sites) was considered to manifest mild stenoses and an intervention was not performed in these grafts to allow the study of progression of vein graft hyperplasia. A second group of six grafts was dilated by a 4.0 mm angioplasty balloon up to 8 atm for 40 seconds. A third group of 12 grafts received a single 4.0 mm stent covering the narrowest arteriovenous anastomosis. A last group of six grafts received two or three stents covering both anastomotic sites and the body of the graft. The implantation procedure of the 4.0 mm balloonexpandable stents was similar to the procedures described earlier for the coronary circulation.i4
After stent implantation and balloon dilatation repeat angiography was performed, the guiding catheter and the introducer sheath were removed, the arteriotomy was repaired, and the skin was closed in two layers. The animals were allowed to recover from anesthesia. After the procedure, antithrombotic uan Beusekom et al. 275 drugs were not administered at any time during the Table I . Number of animals, grafts, and patency rates per follow-up period.
intervention group
Follow-up angiography and harvesting of the specimen. Follow-up angiography was performed after 31 days using the same projection and identical geometry of the x-ray gantry as used during implantation. Thereafter the carotid arteries were dissected free. After cross-clamping and puncturing of the proximal part of the arteries, 500 ml of saline followed by 400 ml of buffered 4 % paraformaldehyde was infused under a pressure of approximately 120 mm Hg. The specimens were placed in 4% paraformaldehyde for light microscopy, or in 4 % paraformaldehyde plus 14, glutaraldehyde in phosphate buffer (pH 7.3) for at least 48 hours in preparation for electron microscopy. analysis. Angiograms (performed immediately before and after intervention and again after 31 days) were analyzed off-line using the quantitative Cardiovascular Measuring System (CMS) software (Medis Medical Imaging Systems, Nuenen, The Netherlands).15 The minimal luminal diameter at the site of the intervention was measured, provided that the angiographic view was not obstructed by the hemoclip. sectioning and staining, microscopy was performed using a light microscope (BH2; Olympus, Tokyo, Japan). Hematoxylin-azophloxin was used as a routine stain, resorcinlfuchsin was used as an elastin stain, and Goldner was used as a trichrome stain. Microscopic analysis. After fixation, the graft-containing arterial segments were divided lengthwise into two equal parts using a pair of fine scissors. One part was washed in 0.1 mol/L cacodylate buffer (pH 7.3) and was postfixed in 1 YO 0~04 in 0.1 mol/L cacodylate buffer for at least 6 hours. After it was washed overnight in 0.1 mol/L cacodylate buffer, the specimen were placed in 1% tannic acid for 60 minutes, in 1 'Z sodium sulfate for 10 minutes, and was again washed in 0.1 mol/L cacodylate buffer. After dehydration in a graded ethanol series and an overnight incubation in uranyl acetate/ethanol (7 parts ethanol 100%; 3 parts uranyl acetate saturated in aqua de&), the specimens were critical point dried with liquid COz, mounted on a specimen table, and sputtercoated with gold before examination in a scanning electron microscope (ISI-DS-130; Akashi Beam Technology, Tokyo, Japan).
Immunocytochemistry.
After rehydration, the sections were exposed to monoclonal mouse anti-smooth muscle cell-specific cu-actin (Sigma Chemical Company, St Louis, MO.), mouse monoclonal anti-porcine vimentin, and mouse anti-porcine desmin (Dakopatts, Glostrup, Denmark) as a marker for smooth muscle cells. As a second antibody, horseradish peroxidase-labeled rabbit anti-mouse antibodies were used (Dakopatts). As a detecting reagent 700 pg/ml of diaminobenzidine (Sigma Chemical Company) in phosphate-buffered saline was used.
Statistical
analysis.
All data are expressed as mean -t SEM, unless otherwise stated. Differences in patency between the intervention groups were analyzed by the chi square test. The significance of the changes in the angiographic data were evaluated by Duncan's new multiple range test once an analysis of variance (ANOVA) had revealed that the samples represented different populations (random block design). A p value less than 0.05 was considered statistically significant.
RESULTS
For light microscopy and immunocytochemistry, 3 to 4 mm wide transverse sections of the second part of the vessels were made with a pair of fine scissors and a sharp razor blade. With tweezers and with the aid of a dissection microscope, the metal stent wires were carefully removed and the tissue was dehydrated and embedded in paraffin. After Vein graft model. Repeat angiography 31 days after surgery showed that 32 grafts (20 animals) out of a total of 58 grafts were angiographically patent (45 % occlusion rate). All occluded grafts were blocked over their entire length, and were excluded from further study.
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Heart Journal Fig. 3 . A, Scanning electron microscopy of a 31-day-old vein graft 2 hours after implantation of the stent revealed trenches (arrow) where the stent wires were located before preparation for microscopy, with thrombus remnants in close apposition (arrowhead). Damage to the vessel wall seems limited to the trenches created by the stent wires, while the remaining endothelium appears undamaged. B, Detail of A showing the apparently undamaged endothelium just above the stent wire.
Hemodynamics during intervention. Immediately before intervention in the grafts, the heart rate was 105 + 5 beats/min, and systolic and diastolic arterial blood pressure measured 129 * 5 and 93 ? 5 mm Hg, respectively.
Acute effect of stenting. The acute effect of stenting was studied by scanning electron microscopy in one animal 4 weeks after surgery at 2 hours after stent placement. The luminal appearance of the vein graft had a waveform geometry after placement of the stent. Because of the open sinusoidal configuration, parts of the vessel wall not covered by the wires were bulging out into the lumen (Fig. 3, A) . At a higher magnification an undulating surface was seen that had an undamaged appearance and that was lined by endothelium. Damage to the vessel wall was only observed at the site where previously the stent wires had been present (Fig. 3, B) .
Angiographic patency 4 weeks after intervention. Qualitative assessment of the angiograms of the four groups revealed that the patency rates after 4 weeks of follow-up of the groups receiving no intervention, those receiving balloon dilatation, or those with a single stent were 83 '% , 83 76, and 92 7% , respectively (Table I ). In the group receiving multiple stents, however, only 17% proved to be patent (p < 0.05 vs all groups). Quantitative angiographic analysis. In all grafts the minimal luminal diameter (MLD) was localized at an anastomotic site. The baseline data show (Fig. 4, A) that the mean MLDs of the intervention groups were smaller than those of the no intervention group, but not significantly different. Balloon dilatation, as well as the placement of single or multiple stents, resulted in a similar immediate improvement of the mean angiographic MLD (0.6 it-0.3,0.8 +-0.3, and 0.5 + 0.2 mm, respectively; Fig. 4, B) . After 4 weeks of followup, no change was observed in the mean MLD of the group without intervention, although some changes in lumen diameter were observed (Fig. 4, B) . All intervention groups showed a significant deterioration of MLD (p < 0.05) when compared with the diameter after intervention, resulting in loss of the initial gain. Although the loss of mean MLD during follow-up tended to be smaller for the single stent group compared with the balloon group, this difference between the groups did not reach levels of statistical significance. The loss in MLD of the multiple stent group (2.4 f 0.2 mm), however, was significantly larger when compared with that of all other groups (Fig. 4, B ; p < 0.05) because of the high occlusion rate of 83 % . When considering only those grafts that remained patent throughout the study, we found that for both balloon angioplasty and single stenting there was no decrease in mean MLD throughout the follow-up period. Only multiple stenting was associ- Histology of the vein graft. The gross morphology of the grafts was variable. Both tight stenoses at the anastomoses and aneurysmal dilatation of the body of the grafts were frequently observed. The adjacent carotid artery was usually normal. In all treated as well as untreated grafts, we observed both medial and neointimal thickening, which consisted of smooth muscle cells (confirmed with a positive staining for anti-smooth muscle cell-specific clc-actin at immunocytochemistry) in a collagenous matrix (Fig. 5) . Most graft segments contained hemosiderin-filled macrophages and inflammatory infiltrates. At the anastomoses we observed inflammatory reactions surrounding the suture and the hemoclip. Macrophages were found containing crystalline inclusions, indicating that the inflammatory response was indeed directed to the 6.0 suture (Prolene, Ethicon, Inc., Somerville, N.J.). In the single stent treatment group, we observed that 4 weeks after stent implantation thrombus remnants surrounding the metal wires were conspicuously present (Fig. 6) . The metal wires were not always embedded in the vessel wall (Fig. 7) . Also, inflammatory infiltrates surrounding the stent wires were observed in the neointima, as well as an occasional multinucleate giant cell. The adjacent carotid arterial side of the anastomosis was less affected.
DISCUSSION
Porcine model of autologous saphenous vein grafting.
The autologous saphenous vein is still the most common conduit for aortocoronary bypass grafts in humans. The vein graft model used in this study (overdistended vena saphena minor interposed in the arteria carotis communis by two end-to-end anastomoses)13 shows extensive intimal hyperplasia that is histologically similar to early graft failure in humans (Fig. 8 ). In this model we compared the behavior of single or multiple balloon-expandable Wiktor stents with the results of balloon angioplasty alone or with the results of no intervention.
Acute effect of stenting of the 31-day-old vein graft.
Scanning electron microscopy revealed that except for the visible damage directly underneath the wires, no apparent damage to the vessel wall was inflicted by the implantation procedure, as demonstrated by the microscopically normal endothelium. Because of the coil configuration of the stent, however, the luminal side was not smooth after the procedure (Fig.  3, A) . The resulting flow disturbances might in turn induce thrombus deposition and persistent endothelial damage, which may both influence the process of intimal hyperplasia.
Angiography.
From the angiograms the grafts were classified during the procedure qualitatively (by visual assessment) either as having only mild stenoses (later quantitatively analyzed as 32 5%) range 23 % to 60%), in which case no further treatment was given, or as having severe stenoses (48%, range 19% to 70 % ), in which case they were assigned to either balloon angioplasty, single stenting, or multiple stenting. Although some differences in angiographic MLD were observed between the intervention groups (Fig. 4 , A), these differences were not statistically significant. In these groups angiography was again performed directly after the intervention.
Comparison with the no intervention group revealed that only in the case of single stenting was a similar MLD created (Fig. 4, B) .
During the 4 weeks of follow-up, a significant deterioration occurred in the mean MLD of all treatment groups. It seems, however, from the angiographic data of the grafts that remained patent throughout the study (Table I and Fig. 4, A and B) that for the single stent and balloon angioplasty groups there are only two possible results in the final outcome. Either the increase in MLD after intervention is maintained or treatment results in total occlusion. Single stenting, however, does seem able to better maintain the procedural increase in MLD than balloon angioplasty alone (Fig. 4, B) .
Histology and immunocytochemistry. Human saphenous vein bypass grafts studied within 1 month after surgery reveal minimal to mild fibrointimal hyperplasia. Some of this narrowing may well be preexisting, since Thiene et a1.i6 reported that of 150 grossly "normal" veins, only 10 were totally free of microscopic phlebosclerosis.
The porcine vein grafts from our study exhibited a more extensive fibrointimal hyperplasia.
The high occlusion rate of 45 % is likely to be the result of overdistention-induced injury and thrombosis superimposed on intimal hyperplasia, as indicated by hemosiderin deposits and neovascularization. Following stent implantation, plasma proteins, platelets, and leukocytes adhere to the metal wires. When compared with healthy, normal vessels, the thrombotic response to injury tends to be more pronounced in vessels with a previous history of disease such as intimal thickening,i7
and might act in synergy with the stent.
From the histology of stented anastomotic sites, we observed that the intimal thickening was more pronounced in the grafts than in the adjacent "normal" carotid artery. Additionally, thrombus remnants that were still conspicuously present in the graft in close apposition to the stent wires were cleared in the carotid artery within the same period. This indicates that either the thrombotic response to this type of injury is indeed more pronounced, or that the organization of the thrombus is delayed or impaired in the graft. More likely is a combination of both, since the incomplete incorporation of the stent in the vessel wall is indicative of a slow-healing wound. In addition, histologic examination of stents in older human vein grafts revealed the persistence of thrombus remnants.t2
Balloon angioplasty versus stenting with single or multiple endoprostheses.
In this model of early saphenous vein graft stenosis, balloon angioplasty and single stents resulted in comparable short-term patency rates and mean MLD. Preliminary clinical results of placement of a self-expanding metal stent in older vein grafts suggest that this treatment has a more favorable clinical course when compared with that of balloon angioplasty.16 The implantation of multiple stents, however, yielded significantly more luminal narrowing at follow-up in our experiments. Therefore our results suggest that the implantation of multiple stents is not indicated in early bypass graft failure. Whether the same applies to late vein graft stenosis remains to be determined, but preliminary reports indicate that in humans, multiple stenting is indeed associated with an increased risk for restenosis.18
Limitations of the study. Several factors may limit the conclusions from this study: (1) The nonrandom distribution of grafts may have been an advantage for the "no intervention" group, because their initial diameter was larger than that of the others. The mean diameter of the grafts that remained patent throughout the study also indicate this to be an important parameter. Although some controversy still exists on the importance of the initial diameter, it was found that a small vessel diameter increased the risk of stent thrombosis, as did the use of small stent sizes.rg (2) Histologic analysis showed that at 2 months inflammatory infiltrates were still present in the untreated grafts and especially at the anastomotic sites. The relatively early interventions (only 1 month after grafting) while healing was still ongoing may have elicited a second more pronounced inflammatory process, which may have disturbed wound healing and increased intimal and medial hyperplasia or even promoted (secondary) thrombotic occlusion. Better results may be expected if the intervention is delayed until healing of the vessel wall is completed.
Conclusions.
The present study shows that single stenting and balloon angioplasty seem able to maintain the increase in MLD during follow-up when patent grafts only are considered, and in the case of single stenting there is less variability. Overall, however, these techniques do not decrease or significantly improve patency (as assessed by angiography) when stents are placed early (within 31 days) after grafting. 
